Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.
The purpose of this work is to develop a thermo-reversible insulin liquid suppository, which undergoes a phase transition to bioadhesive gels at body temperature and enhances the bioavailability of insulin. The effects of insulin and sodium salicylate on the physicochemical properties of a liquid suppository composed of poloxamer P 407, P 188 and polycarbophil were investigated. The pharmacodynamic study and quantitative histological assessment of the rectal mucosa of rats were carried out after the dose of insulin-loaded liquid suppositories with different amounts of sodium salicylate into streptozotocin-treated rats. Only thermo-reversible insulin liquid suppository [insulin/P407/P188/polycarbophil/sodium salicylate (100 (IU/g)/15/20/0.2/10%)] showed the optimal physicochemical properties and good safety in rats. It gave significantly lower plasma glucose levels, AUC(0-->4h) (the area below basal glucose level) and C(nadir) (the plasma glucose levels at the nadir) than did the solid and liquid suppositories without sodium salicylate in rats, indicating that the insulin from liquid suppository with sodium salicylate could be well absorbed in rats due to the absorption enhancing effect of sodium salicylate. It is concluded that thermo-reversible insulin liquid suppository [insulin/P 407/P 188/polycarbophil/sodium salicylate (100 (IU/g)/15/20/0.2/10%)], which was easy to administer without any pain during insertion and remained at the administered sites, could have a potential to be developed as a more convenient, safe and effective rectal delivery system of insulin.
Yun
M
M
College of Pharmacy, Seoul National University, San 56-1 Shinlim-Dong, Kwanak-Ku, Seoul, South Korea. ckkim@plaza.snu.ac.kr
Choi
H
H
Jung
J
J
Kim
C
C
D000285:Administration, Rectal; D000818:Animals; D019540:Area Under Curve; D001682:Biological Availability; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001831:Body Temperature; D055598:Chemical Phenomena; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D002627:Chemistry, Physical; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004355:Drug Stability; D005782:Gels; D066298:In Vitro Techniques; D007328:Insulin / Q000737:chemistry / Q000493:pharmacokinetics*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D008297:Male; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D012007:Rectum / Q000187:drug effects / Q000378:metabolism; D012980:Sodium Salicylate / Q000494:pharmacology; D012996:Solutions; D013488:Suppositories; D013552:Swine; D013696:Temperature
D001786:Blood Glucose; D005782:Gels; D007328:Insulin; D012996:Solutions; D013488:Suppositories; D012980:Sodium Salicylate